乳酸-铁恒温的调节剂及其在癌症中的影响
Izabela Bolesławska1, Natasza Bolesławska-Król2, Karol Jakubowski1
1Department of Bromatology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
Molecules (Basel, Switzerland)
|April 26, 2025
概括
乳酸 (LF) 可以通过控制铁含量,减少氧化压力和增强免疫系统来对抗癌症. 这种糖蛋白在癌症预防和治疗方面表现有前途,需要进一步的临床研究.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
背景情况:
- 癌症的进展与铁代谢的改变密切相关.
- 癌细胞对扩散,入侵和转移的铁需求增加.
- 不调节的铁代谢有助于癌症相关的贫血,铁过载和肠道失调.
研究的目的:
- 审查乳酸铁素 (LF) 影响癌症的机制.
- 为了突出LF在癌症中的铁化,抗氧化和免疫调节性质.
- 评估LF在癌症预防和治疗中的潜力.
主要方法:
- 文献综述侧重于LF在癌症中的作用.
- 对LF对铁代谢,氧化应激和免疫反应的影响的分析.
- 检查LF对癌细胞增殖,入侵和转移的影响.
主要成果:
- 乳酸 (LF) 有效合铁,限制其可供癌细胞使用.
- 通过减少自由铁离子,LF减轻了氧化应激,从而抑制了癌症发生.
- 肺炎表现出免疫调节和抗炎作用,可能增强抗瘤免疫力.
结论:
- 乳酸的多方面的作用,包括铁化和免疫调节,使其成为癌症管理中的有希望的药物.
- 的抗氧化和抗癌性质支持其在预防策略中的作用.
- 需要进行进一步的临床研究,才能充分确定乳酸铁在癌症患者中的治疗效果.
相关概念视频
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Positive Regulator Molecules
105.6K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
105.6K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
The Nucleolus
8.6K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K


